EX-10.8



 Exhibit 10.8 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
 PLEDGE AND SECURITY
AGREEMENT 
 This PLEDGE AND SECURITY AGREEMENT, dated as of March 12, 2014 (as amended, supplemented or otherwise modified from time
to time, this “Security Agreement”), is made by UNILIFE MEDICAL SOLUTIONS, INC., a Delaware corporation (the “Borrower”), UNILIFE CORPORATION, a Delaware corporation (“Holdings”), Unilife Cross Farm
LLC, a Delaware limited liability company (“Cross Farm”), UNILIFE MEDICAL SOLUTIONS PTY LIMITED, a company registered in South Australia with ACN 008 071 403 (“Solutions”) and UNITRACT SYRINGE PTY LTD, a company
registered in Western Australia with ACN 101 059 723 (“Syringe”; and together with the Borrower, Holdings, Cross Farm and Solutions, and any other entity that may become a party hereto as provided herein, each a
“Grantor” and, collectively, the “Grantors”) in favor of ROS ACQUISITION OFFSHORE LP, a Cayman Islands exempted limited partnership (together with its successors, transferees and assignees, the
“Lender”), for itself and as agent for ROYALTY OPPORTUNITIES S.À R.L, a Luxembourg société à responsabilité limitée (together with its successors, transferees and assignees,
“ROS”) and the other parties to which the Grantors may owe any Obligations (together with the Lender and ROS, the “Secured Parties” and each, a “Secured Party”). 

W I T N E S S E T H : 

WHEREAS, pursuant to the Credit Agreement, dated as of the date hereof (as the same may be amended, supplemented or otherwise modified from
time to time, the “Credit Agreement”), by and between the Borrower and the Lender, the Lender has extended a Commitment to make Loans to the Borrower; and 

WHEREAS, as a condition precedent to the making of the Initial Loan under the Credit Agreement and entering into the other Loan Documents,
each Grantor is required to execute and deliver this Security Agreement; 
 NOW, THEREFORE, for good and valuable consideration, the receipt
and sufficiency of which are hereby acknowledged, each Grantor agrees, for the benefit of the Lender, as follows: 
 ARTICLE I 

DEFINITIONS 
 SECTION 1.1.
Certain Terms. The following terms (whether or not underscored) when used in this Security Agreement, including its preamble and recitals, shall have the following meanings (such definitions to be equally applicable to the singular and plural
forms thereof): 
 “Borrower” is defined in the preamble. 

  
 1 









 Exhibit 10.8 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 “Collateral” is defined in Section 2.1. 

“Collateral Accounts” is defined in Section 4.3(b). 

“Computer Hardware and Software Collateral” means (a) all of the Grantors’ computer and other electronic data
processing hardware, integrated computer systems, central processing units, memory units, display terminals, printers, features, computer elements, card readers, tape drives, hard and soft disk drives, cables, electrical supply hardware, generators,
power equalizers, accessories and all peripheral devices and other related computer hardware, including all operating system software, utilities and application programs in whatsoever form; (b) all software programs (including both source code,
object code and all related applications and data files) designed for use on the computers and electronic data processing hardware described in clause (a) above; (c) all firmware associated therewith; (d) all documentation
(including flow charts, logic diagrams, manuals, guides, specifications, training materials, charts and pseudo codes) with respect to such hardware, software and firmware described in the preceding clauses (a) through (c); and
(e) all rights with respect to all of the foregoing, including copyrights, licenses, options, warranties, service contracts, program services, test rights, maintenance rights, support rights, improvement rights, renewal rights and
indemnifications and any substitutions, replacements, improvements, error corrections, updates, additions or model conversions of any of the foregoing. 

“Control Agreement” means an authenticated record in form and substance reasonably satisfactory to the Lender, that provides
for the Lender to have “control” (as defined in the UCC) over certain Collateral. 
 “Copyright Collateral” means
all copyrights of the Grantors, whether statutory or common law, whether registered or unregistered and whether published or unpublished, now or hereafter in force throughout the world including all of the Grantors’ rights, titles and interests
in and to all copyrights registered in the United States Copyright Office or anywhere else in the world, including the copyrights referred to in Item A of Schedule V, and registrations and recordings thereof and all applications for
registration thereof, whether pending or in preparation, all copyright licenses, including each copyright license referred to in Item B of Schedule V, the right to sue for past, present and future infringements of any of the foregoing,
all rights corresponding thereto, all extensions and renewals of any thereof and all Proceeds of the foregoing, including licenses, royalties, income, payments, claims, damages and Proceeds of suit, which are owned or licensed by the Grantors. 

“Credit Agreement” is defined in the first recital. 

“Distributions” means all dividends paid on Capital Securities, liquidating dividends paid on Capital Securities, shares (or
other designations) of Capital Securities resulting from (or in connection with the exercise of) stock splits, reclassifications, warrants, options, non-cash dividends, mergers, consolidations, and all other
distributions (whether similar or dissimilar to the foregoing) on or with respect to any Capital Securities constituting Collateral. 

  
 2 









 Exhibit 10.8 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 “Filing Statements” is defined in Section 3.7(b). 

“General Intangibles” means all “general intangibles” and all “payment intangibles”, each as defined in
the UCC, and shall include all interest rate or currency protection or hedging arrangements, all tax refunds, all licenses, permits, concessions and authorizations and all Intellectual Property Collateral (in each case, regardless of whether
characterized as general intangibles under the UCC). 
 “Grantor” and “Grantors” are defined in the
preamble. 
 “[***]” has the meaning given such term in the [***]. 

“Intellectual Property Collateral” means, collectively, the Computer Hardware and Software Collateral, the Copyright
Collateral, the Patent Collateral, the Trademark Collateral, the Trade Secrets Collateral, Product Agreements and Regulatory Authorizations. 

“Intercompany Note” means any promissory note evidencing loans made by any Grantor to any other Grantor. 

“Investment Property” means, collectively, (a) all “investment property” as such term is defined in
Section 9-102(a)(49) of the UCC and (b) whether or not constituting “investment property” as so defined, all Pledged Notes. 

“Lender” is defined in the preamble. 

“Patent Collateral” means: 

(a) all of the Grantors’ (i) inventions and discoveries, whether patentable or not, and (ii) letters patent and
applications for letters patent throughout the world, including all patent applications in preparation for filing and each patent and patent application referred to in Item A of Schedule III; 

(b) all reissues, divisions, continuations,
continuations-in-part, extensions, renewals and reexaminations of any of the items described in clause (a); 

(c) all patent licenses, and other agreements providing any Grantor with the right to use any items of the type referred to in
clauses (a) and (b) above, including each patent license referred to in Item B of Schedule III; and 

(d) all Proceeds of, and rights associated with, the foregoing (including licenses, royalties income, payments, claims, damages
and Proceeds of infringement suits) and the right to sue third parties for past, present or future infringements of any patent or patent application and for breach or enforcement of any patent license. 

  
 3 









 Exhibit 10.8 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 “Permitted Liens” means all Liens permitted by Section 8.3 of the
Credit Agreement. 
 “Pledged Notes” means all promissory notes listed on Item J of Schedule II (as such
schedule may be amended or supplemented from time to time), all Intercompany Notes at any time issued to any Grantor and all other promissory notes issued to or held by any Grantor. 

“ROS” is defined in the preamble. 

“Securities Act” is defined in Section 6.2(a). 

“Security Agreement” is defined in the preamble. 

“Trade Secrets Collateral” means all of the Grantors’ common law and statutory trade secrets and all other confidential,
proprietary or useful information, and all know-how obtained by or used in or contemplated at any time for use in the business of any Grantor (all of the foregoing being collectively called a “Trade
Secret”), whether or not such Trade Secret has been reduced to a writing or other tangible form, including all documents and things embodying, incorporating or referring in any way to such Trade Secret, all Trade Secret licenses, including
each Trade Secret license referred to in Schedule VI, and including the right to sue for and to enjoin and to collect damages for the actual or threatened misappropriation of any Trade Secret and for the breach or enforcement of any such
Trade Secret license. 
 “Trademark Collateral” means: 

(a) (i) all of the Grantors’ trademarks, trade names, corporate names, company names, business names, fictitious business
names, trade styles, service marks, certification marks, collective marks, logos and other source or business identifiers, and all goodwill of the business associated therewith, now existing or hereafter adopted or acquired including those referred
to in Item A of Schedule IV, whether currently in use or not, all registrations and recordings thereof and all applications in connection therewith, whether pending or in preparation for filing, including registrations, recordings and
applications in the United States Patent and Trademark Office or in any office or agency of the United States of America, or any State thereof or any other country or political subdivision thereof or otherwise, and all
common-law rights relating to the foregoing, and (ii) the right to obtain all reissues, extensions or renewals of the foregoing (collectively referred to as the “Trademarks”); 

(b) all Trademark licenses for the grant by or to any Grantors of any right to use any Trademark, including each Trademark
license referred to in Item B of Schedule IV; and 
 (c) all of the goodwill of the business connected with the
use of, and symbolized by the items described in, clause (a), and to the extent applicable clause (b); 

  
 4 









 Exhibit 10.8 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 (d) the right to sue third parties for past, present and future infringements
of any Trademark Collateral described in clause (a) and, to the extent applicable, clause (b); and 
 (e)
all Proceeds of, and rights associated with, the foregoing, including any claim by any Grantor against third parties for past, present or future infringement or dilution of any Trademark, Trademark registration or Trademark license, or for any
injury to the goodwill associated with the use of any such Trademark or for breach or enforcement of any Trademark license and all rights corresponding thereto throughout the world. 

SECTION 1.2. Credit Agreement Definitions. Unless otherwise defined herein or the context otherwise requires, terms used in this
Security Agreement, including its preamble and recitals, have the meanings provided in the Credit Agreement. 
 SECTION 1.3. UCC
Definitions. When used herein the terms “Account”, “Certificate of Title”, “Certificated Securities”, “Chattel Paper”, “Commercial Tort Claim”, “Commodity Account”, “Commodity
Contract”, “Deposit Account”, “Document”, “Electronic Chattel Paper”, “Equipment”, “Goods”, “Instrument”, “Inventory”, “Letter-of-Credit Rights”, “Payment
Intangibles”, “Proceeds”, “Promissory Notes”, “Securities Account”, “Security Entitlement”, “Supporting Obligations” and “Uncertificated Securities” have the meaning provided in
Article 8 or Article 9, as applicable, of the UCC. “Letters of Credit” has the meaning provided in Section 5-102 of the UCC. 

SECTION 1.4. Interpretation. The provisions of Section 1.5 of the Credit Agreement are incorporated in, and apply to, this
Agreement as if set out in full with any necessary amendments. 
 ARTICLE II 

SECURITY INTEREST 
 SECTION 2.1.
Grant of Security Interest. Each Grantor hereby grants to the Lender, for its benefit, a continuing security interest in all of such Grantor’s right, title and interest in and to the following property, whether now or hereafter existing,
owned or acquired by such Grantor, and wherever located, (collectively, the “Collateral”): 
 (a) Accounts;

 (b) Chattel Paper; 

(c) Commercial Tort Claims listed on Item I of Schedule II (as such schedule may be amended or supplemented from
time to time); 

  
 5 









 Exhibit 10.8 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 (d) Deposit Accounts; 

(e) Documents; 

(f) General Intangibles; 

(g) Goods (including Goods held on consignment with third parties); 

(h) Instruments; 

(i) Investment Property; 

(j) Letter-of-Credit Rights and Letters of Credit; 

(k) Supporting Obligations; 

(l) all books, records, writings, databases, information and other property relating to, used or useful in connection with,
evidencing, embodying, incorporating or referring to, any of the foregoing in this Section (collectively, “Collateral Records”); 

(m) all Proceeds of the foregoing and, to the extent not otherwise included, (A) all payments under insurance (whether or
not the Lender is the loss payee thereof) in respect of Collateral and (B) all tort claims; and 
 (n) all other
property and rights of every kind and description and interests therein. 
 Notwithstanding the foregoing, the term “Collateral”
shall not include the following “Excluded Property”: 
 (i) any General Intangibles or other rights arising
under any contracts, instruments, licenses or other documents as to which the grant of a security interest would (A) constitute a violation of a valid and enforceable restriction in favor of a third party on such grant, unless and until any
required consents shall have been obtained, or (B) give any other party to such contract, instrument, license or other document the right to terminate its obligations thereunder; 

(ii) trademark applications filed in the United States Patent and Trademark Office on the basis of such Grantor’s
“intent to use” such trademark, unless and until acceptable evidence of use of the Trademark has been filed with the United States Patent and Trademark Office pursuant to Section 1(c) or Section 1(d) of the Lanham Act (15 U.S.C.
1051, et seq.), to the extent that granting a Lien in such Trademark application prior to such filing would adversely affect the enforceability or validity of such Trademark application; 

  
 6 









 Exhibit 10.8 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 (iii) any asset, the granting of a security interest in which would be void
or illegal under any applicable governmental law, rule or regulation, or pursuant thereto would result in, or permit the termination of, such asset; 

(iv) any asset subject to a Permitted Lien (other than Liens in favor of the Lender) securing obligations permitted under the
Credit Agreement to the extent that the grant of other Liens on such asset (A) would result in a breach or violation of, or constitute a default under, the agreement or instrument governing such Permitted Lien, (B) would result in the loss
of use of such asset or (C) would permit the holder of such Permitted Lien to terminate the Grantor’s use of such asset; 

(v) the accounts described in paragraphs (ii) and (iv) of the definition of Excluded Accounts; or 

(vi) [***]; 

provided, that the property described in paragraphs (i), (iii) and (iv) above shall only be excluded from the term
“Collateral” to the extent the conditions stated in such paragraphs are not rendered ineffective pursuant to Sections 9-406, 9-407, 9-408 or 9-409 of the UCC or any other applicable law and the term “Excluded Property” shall not
include any proceeds, products, substitutions or replacements of Excluded Property (unless such proceeds, products, substitutions or replacements would otherwise constitute Excluded Property). 

SECTION 2.2. Security for Obligations. This Security Agreement and the Collateral in which the Lender is granted a security interest
hereunder by the Grantors secure the payment and performance of all of the Obligations. 
 SECTION 2.3. Grantors Remain Liable.
Anything herein to the contrary notwithstanding: 
 (a) the Grantors will remain liable under the contracts and agreements
included in the Collateral to the extent set forth therein, and will perform all of their duties and obligations under such contracts and agreements to the same extent as if this Security Agreement had not been executed; 

(b) the exercise by the Lender of any of its rights hereunder will not release any Grantor from any of its duties or
obligations under any such contracts or agreements included in the Collateral; and 

  
 7 









 Exhibit 10.8 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 (c) the Lender will not have any obligation or liability under any contracts
or agreements included in the Collateral by reason of this Security Agreement, nor will the Lender be obligated to perform any of the obligations or duties of any Grantor thereunder or to take any action to collect or enforce any claim for payment
assigned hereunder. 
 SECTION 2.4. Distributions on Capital Securities; Payments on Pledged Notes. In the event that any
(a) Distribution with respect to any Capital Securities or (b) payment with respect to any Pledged Notes, in each case pledged hereunder, is permitted to be paid (in accordance with Section 8.6 of the Credit Agreement), such
Distribution or payment may be paid directly to the applicable Grantor. If any Distribution or payment is made in contravention of Section 8.6 of the Credit Agreement, such Grantor shall hold the same segregated and in trust for the Lender
until paid to the Lender in accordance with Section 4.1.5. 
 SECTION 2.5. Security Interest Absolute, Etc. This Security
Agreement shall in all respects be a continuing, absolute, unconditional and irrevocable grant of security interest, and shall remain in full force and effect until the Termination Date. All rights of the Lender and the security interests granted to
the Lender hereunder, and all obligations of the Grantors hereunder, shall, to the fullest extent permitted by applicable law, in each case, be absolute, unconditional and irrevocable irrespective of: 

(a) any lack of validity, legality or enforceability of any Loan Document (other than this Security Agreement); 

(b) the failure of the Lender (i) to assert any claim or demand or to enforce any right or remedy against Holdings, the
Borrower or any of the Subsidiaries or any other Person (including any other Grantor) under the provisions of any Loan Document or otherwise, or (ii) to exercise any right or remedy against any other guarantor (including any other Grantor) of,
or Collateral securing, any Obligations; 
 (c) any change in the time, manner or place of payment of, or in any other term
of, all or any part of the Obligations, or any other extension, compromise or renewal of any Obligations; 
 (d) any
reduction, limitation, impairment or termination of any Obligations for any reason, including any claim of waiver, release, surrender, alteration or compromise, and shall not be subject to (and each Grantor hereby waives, until payment of all
Obligations, any right to or claim of) any defense or setoff, counterclaim, recoupment or termination whatsoever by reason of the invalidity, illegality, nongenuineness, irregularity, compromise, unenforceability of, or any other event or occurrence
affecting, any Obligations or otherwise; 

  
 8 









 Exhibit 10.8 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 (e) any amendment to, rescission, waiver, or other modification of, or any
consent to or departure from, any of the terms of any Loan Document; 
 (f) any addition, exchange or release of any
Collateral or of any Person that is (or will become) a Grantor (including the Grantors hereunder), or any surrender or non-perfection of any Collateral, or any amendment to or waiver or release or addition to, or consent to or departure from, any
other guaranty held by the Lender securing any of the Obligations; or 
 (g) any other circumstance which might otherwise
constitute a defense available to, or a legal or equitable discharge of Holdings, the Borrower or any of the Subsidiaries, any surety or any guarantor. 

SECTION 2.6. Postponement of Subrogation. Each Grantor agrees that it will not exercise any rights against another Grantor which it may
acquire by way of rights of subrogation under any Loan Document to which it is a party until following the Termination Date. No Grantor shall seek or be entitled to seek any contribution or reimbursement from Holdings, the Borrower or any of the
Subsidiaries, in respect of any payment made under any Loan Document or otherwise, until following the Termination Date. Any amount paid to any Grantor on account of any such subrogation rights prior to the Termination Date shall be held in trust
for the benefit of the Lender and shall immediately be paid and turned over to the Lender in the exact form received by such Grantor (duly endorsed in favor of the Lender, if required), to be credited and applied against the Obligations, whether
matured or unmatured, in accordance with Section 6.1(b); provided that if such Grantor has made payment to the Lender of all or any part of the Obligations and the Termination Date has occurred, then at such Grantor’s
request, the Lender will, at the expense of such Grantor, execute and deliver to such Grantor appropriate documents (without recourse and without representation or warranty) necessary to evidence the transfer by subrogation to such Grantor of an
interest in the Obligations resulting from such payment. In furtherance of the foregoing, at all times prior to the Termination Date, such Grantor shall refrain from taking any action or commencing any proceeding against Holdings, the Borrower or
any of the Subsidiaries (or their successors or assigns, whether in connection with a bankruptcy proceeding or otherwise) to recover any amounts in respect of payments made under this Security Agreement to the Lender. 

ARTICLE III 
 REPRESENTATIONS AND
WARRANTIES 
 In order to induce the Lender to enter into the Credit Agreement and make the Loans thereunder, the Grantors represent and
warrant to the Lender as set forth below. 
 SECTION 3.1. As to Capital Securities of the Subsidiaries, Investment Property. 

  
 9 









 Exhibit 10.8 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 (a) With respect to any U.S. Subsidiary of any Grantor that is 

(i) a corporation, business trust, joint stock company or similar Person, all Capital Securities issued by such Subsidiary
(including the Borrower) are duly authorized and validly issued, fully paid and non-assessable, and represented by a certificate or certificates; and 

(ii) a partnership or limited liability company, no Capital Securities issued by such Subsidiary (A) are dealt in or
traded on securities exchanges or in securities markets, (B) expressly provides that such Capital Securities is a security governed by Article 8 of the UCC or (C) is held in a Securities Account, except, with respect to this clause
(a)(ii), Capital Securities (x) for which the Lender is the registered owner or (y) with respect to which the issuer has agreed in an authenticated record with such Grantor and the Lender to comply with any instructions of the Lender
without the consent of such Grantor. 
 (b) Each Grantor has delivered all Certificated Securities constituting Collateral
held by such Grantor in a Subsidiary (including the Borrower) on the Closing Date (or the date such Grantor becomes a party to this Security Agreement, as applicable) to the Lender, together with duly executed undated blank stock powers, or other
equivalent instruments of transfer acceptable to the Lender. 
 (c) With respect to Uncertificated Securities constituting
Collateral owned by any Grantor in a Subsidiary (including the Borrower) on the Closing Date (or the date such Grantor becomes a party to this Security Agreement, as applicable), such Grantor has caused the issuer thereof either to (i) register
the Lender as the registered owner of such security or (ii) agree in an authenticated record with such Grantor and the Lender that such issuer will comply with instructions with respect to such security originated by the Lender without further
consent of such Grantor. 
 (d) The percentage of the issued and outstanding Capital Securities of each Subsidiary (including
the Borrower) pledged on the Closing Date by each Grantor hereunder is as set forth on Schedule I. All shares of such Capital Securities have been duly and validly issued and are fully paid and nonassessable. 

(e) Each of the Intercompany Notes constitutes the legal, valid and binding obligation of the obligor with respect thereto,
enforceable in accordance with its terms, subject to the effects of bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium and other similar laws relating to or affecting creditors’ rights generally, general equitable
principles (whether considered in a proceeding in equity or at law) and an implied covenant of good faith and fair dealing. 

  
 10 









 Exhibit 10.8 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 SECTION 3.2. Grantor Name, Location, Etc. In each case as of the date hereof: 

(a) (i) The jurisdiction in which each Grantor is located for purposes of Sections
9-301 and 9-307 of the UCC and (ii) the address of each Grantor’s executive office and principal place of business is set forth in Item A of Schedule
II. 
 (b) The Grantors do not have any trade names other than those set forth in Item C of Schedule II
hereto. 
 (c) During the twelve months preceding the date hereof (or preceding the date such Grantor becomes a party to this
Security Agreement, as applicable), no Grantor has been known by any legal name different from the one set forth on the signature page hereto, nor has such Grantor been the subject of any merger or other corporate reorganization, except as set forth
in Item D of Schedule II hereto. 
 (d) Each Grantor’s federal taxpayer identification number (or foreign
equivalent) is (and, during the twelve months preceding the date hereof, such Grantor has not had a federal taxpayer identification number (or equivalent) different from that) set forth in Item E of Schedule II hereto. 

(e) No Grantor is a party to any federal, state or local government contract except as set forth in Item F of
Schedule II hereto. 
 (f) No Grantor maintains any Deposit Accounts, Securities Accounts or Commodity Accounts with
any Person, in each case, except as set forth on Item G of Schedule II. 
 (g) No Grantor is the beneficiary of
any Letters of Credit, except as set forth on Item H of Schedule II. 
 (h) No Grantor has Commercial Tort
Claims except as set forth on Item I of Schedule II. 
 (i) The name set forth on the signature page attached
hereto is the true and correct legal name (as defined in the UCC) of each Grantor. 
 SECTION 3.3. Ownership, No Liens, Etc. Each
Grantor owns its Collateral free and clear of any Lien, except for any security interest (a) created by this Security Agreement and (b) Permitted Liens. No effective UCC financing statement or other filing similar in effect covering all or
any part of the Collateral is on file in any recording office, except those filed in favor of the Lender relating to this Security Agreement, Permitted Liens or as to which a duly authorized termination statement relating to such UCC financing
statement or other instrument has been delivered to the Lender on the Closing Date. 

  
 11 









 Exhibit 10.8 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 SECTION 3.4. Possession of Inventory, Control, Etc. 

(a) Each Grantor has, and agrees that it will maintain, exclusive possession of its Documents, Instruments, Promissory Notes,
Goods, Equipment and Inventory, other than (i) Equipment and Inventory that is in transit in the ordinary course of business, (ii) Equipment and Inventory that in the ordinary course of business is in the possession or control of a
warehouseman, bailee agent or other Person (other than a Person controlled by or under common control with such Grantor) that has been notified of the security interest created in favor of the Lender pursuant to this Security Agreement and has
authenticated a record acknowledging that it holds possession of such Collateral for the Lender’s benefit and waives any Lien held by it against such Collateral, (iii) Inventory that is in the possession of a consignee in the ordinary
course of business, (iv) Instruments or Promissory Notes that have been delivered to the Lender pursuant to Section 3.5, and (v) Equipment and Inventory at any single location which does not meet the requirements of
sub-sections (i), (ii), (iii) or (iv) above, but the value of such Equipment and Inventory at such location is not in an aggregate amount of more than $[***]. In the case of Equipment or Inventory described in clause
(ii) above, no lessor or warehouseman of any premises or warehouse upon or in which such Equipment or Inventory is located has (w) issued any warehouse receipt or other receipt in the nature of a warehouse receipt in respect of any
such Equipment or Inventory, (x) issued any Document for any such Equipment or Inventory, or (y) received notification of the Lender’s interest (other than the security interest granted hereunder) in any such Equipment or Inventory or
(z) any Lien on any such Equipment or Inventory. All Collateral Records of the Grantors are maintained at or accessible from the locations set forth in Item A of Schedule II. 

(b) Each Grantor is the sole entitlement holder of its Deposit Accounts (other than the Excluded Accounts) and no other Person
(other than the Lender pursuant to this Security Agreement or any other Person with respect to Permitted Liens) has control or possession of, or any other interest in, any of its Deposit Accounts (other than the Excluded Accounts) or any other
securities or property credited thereto. 
 SECTION 3.5. Negotiable Documents, Instruments and Chattel Paper. Each Grantor has
delivered to the Lender possession of all originals of all Documents, Instruments, Promissory Notes, and tangible Chattel Paper (other than any Document, Instrument, Promissory Note or tangible Chattel Paper not exceeding $[***] in principal amount)
owned or held by such Grantor on the Closing Date. 
 SECTION 3.6. Intellectual Property Collateral. Except as disclosed on
Schedules III through VI, with respect to any Intellectual Property Collateral: 

  
 12 









 Exhibit 10.8 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 (a) any Intellectual Property Collateral owned by any Grantor is valid,
subsisting, unexpired ahead of its natural expiration or term, and enforceable and has not been abandoned by the Grantor or adjudged invalid or unenforceable, in whole or in part; 

(b) such Grantor is the sole and exclusive owner of the entire and unencumbered right, title and interest in and to all
Intellectual Property Collateral owned by such Grantor and to the knowledge of such Grantor, no claim has been made that the use of such Intellectual Property Collateral by such Grantor does or may, conflict with, infringe, misappropriate, dilute,
misuse or otherwise violate in any material respect, any of the rights of any third party; 
 (c) such Grantor has made all
necessary filings and recordations to protect its interest in any Intellectual Property Collateral owned by such Grantor to the extent such filing or recordation is necessary for the conduct of the business substantially in the manner presently
conducted, including recordations of all of its interests in the Patent Collateral and Trademark Collateral in the United States Patent and Trademark Office (or foreign equivalent), and its claims to the Copyright Collateral in the United States
Copyright Office (or foreign equivalent), and, to the extent necessary, has used proper statutory notice in connection with its use of any material Patent, Trademark and Copyright in any of the Intellectual Property Collateral; 

(d) such Grantor has taken reasonable steps to safeguard its Trade Secrets and to its knowledge (A) none of the Trade
Secrets of such Grantor has been used, divulged, disclosed or appropriated for the benefit of any other Person other than such Grantor; (B) no employee, independent contractor or agent of such Grantor has misappropriated any Trade Secrets of
any other Person in the course of the performance of his or her duties as an employee, independent contractor or agent of such Grantor; and (C) no employee, independent contractor or agent of such Grantor is in default or breach of any material
term of any employment agreement, non-disclosure agreement, assignment of inventions agreement or similar agreement or contract relating in any material way to the protection, ownership, development, use or transfer of such Grantor’s
Intellectual Property Collateral; 
 (e) to such Grantor’s knowledge, no third party is infringing upon any Intellectual
Property owned or used by such Grantor in any material respect; 
 (f) no settlement or consents, covenants not to sue,
nonassertion assurances, or releases have been entered into by such Grantor or to which such Grantor is bound that adversely affects its rights to own or use any Intellectual Property; 

(g) [***]; 

  
 13 









 Exhibit 10.8 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 (h) such Grantor has executed and delivered to the Lender Intellectual
Property Collateral security agreements for all Copyrights, Patents and Trademarks owned by such Grantor, including all Copyrights, Patents and Trademarks on Schedule III through VI (as such schedules may be amended or supplemented
from time to time by notice by such Grantor to the Lender); 
 (i) such Grantor uses commercially reasonable standards of
quality in the manufacture, distribution, and sale of all products sold and in the provision of all services rendered under or in connection with all Trademarks and has taken commercially reasonable action necessary to insure that all licensees of
the Trademarks owned by such Grantor use such adequate standards of quality; 
 (j) the consummation of the transactions
contemplated by the Credit Agreement and this Security Agreement will not result in the termination or material impairment of any of the Intellectual Property Collateral; and 

(k) to such Grantor’s knowledge, such Grantor owns or is entitled to use by license, lease or other agreement, all
Patents, Trademarks, Trade Secrets, Copyrights, mask works, licenses, technology, know-how, processes and rights with respect to any of the foregoing as necessary to conduct the business and operations of such
Grantor substantially in the manner presently conducted. 
 SECTION 3.7. Validity, Etc.  

(a) This Security Agreement creates a valid security interest in the Collateral securing the payment of the Obligations to the
extent such security interest may be created pursuant to Article 9 of the UCC. 
 (b) As of the Closing Date, each Grantor
has filed or will cause to be filed all UCC-1 financing statements in the filing office for each Grantor’s jurisdiction of organization listed in Item A of Schedule II (collectively, the “Filing Statements”) (or
has delivered to the Lender the Filing Statements suitable for timely and proper filing in such offices) and has taken all other actions required by the Lender for the Lender to obtain control (either itself or through an agent) of the Collateral as
provided in Sections 9-104, 9-105, 9-106 and 9-107 of the UCC. 
 (c) Upon the filing of the Filing Statements with the
appropriate agencies therefor the security interests created under this Security Agreement shall constitute a perfected security interest in the Collateral described on such Filing Statements in favor of the Lender to the extent that a security
interest therein may be perfected by filing a financing statement pursuant to the relevant UCC, prior to all other Liens, except for Permitted Liens (in which case such security interest shall have such priority of right contemplated by the Loan
Documents and subject only to the Permitted Liens until the obligations secured by such Permitted Liens have been satisfied, except as expressly specified in the Loan Documents). 

  
 14 









 Exhibit 10.8 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 SECTION 3.8. Authorization, Approval, Etc. Except as have been obtained or made and
are in full force and effect, no authorization, approval or other action by, and no notice to or filing with, any Governmental Authority or any other third party is required either 

(a) for the grant by the Grantors of the security interest granted hereby or for the execution, delivery and performance of
this Security Agreement by the Grantors; 
 (b) for the perfection or maintenance of the security interests hereunder
including the first priority nature of such security interest (except with respect to the Filing Statements or, with respect to Intellectual Property Collateral, the recordation of any agreements with the United States Patent and Trademark Office or
the United States Copyright Office or, with respect to foreign Intellectual Property Collateral, the taking of appropriate action under applicable foreign law and, with respect to after-acquired Intellectual Property Collateral, any subsequent
filings in United States intellectual property offices) or the exercise by the Lender of its rights and remedies hereunder; or 

(c) for the exercise by the Lender of the voting or other rights provided for in this Security Agreement, except (i) with
respect to any securities issued by a Subsidiary of the Grantors, as may be required in connection with a disposition of such securities by laws affecting the offering and sale of securities generally, the remedies in respect of the Collateral
pursuant to this Security Agreement and (ii) any “change of control” or similar filings required by state licensing agencies. 

SECTION 3.9. Best Interests. It is in the best interests, and for the commercial benefit, of each Grantor (other than the Borrower) to
execute this Security Agreement inasmuch as such Grantor will, as a result of being an Affiliate of the Borrower, derive substantial direct and indirect benefits from the Loans made to the Borrower by the Lender pursuant to the Credit Agreement, and
each Grantor agrees that the Lender is relying on this representation in agreeing to make such Loans pursuant to the Credit Agreement to the Borrower. 

ARTICLE IV 
 COVENANTS 

Each Grantor covenants and agrees that, until the Termination Date, such Grantor will perform, comply with and be bound by the obligations set
forth below. 
 SECTION 4.1. As to Investment Property, Etc. 

  
 15 









 Exhibit 10.8 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 SECTION 4.1.1. Capital Securities of Subsidiaries. No Grantor will allow any of its
Subsidiaries (including the Borrower): 
 (a) that is a corporation, business trust, joint stock company or similar Person,
to issue Uncertificated Securities; 
 (b) that is a partnership or limited liability company, to (i) issue Capital
Securities that are to be dealt in or traded on securities exchanges or in securities markets, (ii) expressly provide in its Organic Documents that its Capital Securities are securities governed by Article 8 of the UCC, or (iii) place such
Subsidiary’s Capital Securities in a Securities Account; and 
 (c) to issue Capital Securities in addition to or in
substitution for the Capital Securities pledged hereunder, except to such Grantor (and such Capital Securities are immediately pledged and delivered to the Lender pursuant to the terms of this Security Agreement). 

SECTION 4.1.2. Investment Property (other than Certificated Securities). 

(a) With respect to any Deposit Accounts, Securities Accounts, Commodity Accounts, Commodity Contracts or Security Entitlements
constituting Investment Property owned or held by any Grantor, such Grantor will cause (except for Excluded Accounts) the intermediary maintaining such Investment Property to execute a Control Agreement relating to such Investment Property pursuant
to which such intermediary agrees to comply with the Lender’s instructions with respect to such Investment Property without further consent by such Grantor. 

(b) With respect to any Uncertificated Securities (other than Uncertificated Securities credited to a Securities Account)
constituting Investment Property owned or held by any Grantor, such Grantor will cause the issuer of such securities to either (i) register the Lender as the registered owner thereof on the books and records of the issuer or (ii) execute a
Control Agreement relating to such Investment Property pursuant to which the issuer agrees to comply with the Lender’s instructions with respect to such Uncertificated Securities without further consent by such Grantor. Each party hereto that
is such an issuer of any Uncertificated Securities herby agrees that such party will comply with instructions with respect to such security originated by the Lender. 

SECTION 4.1.3. Certificated Securities (Stock Powers). Each Grantor agrees that all Certificated Securities constituting Collateral,
including the Capital Securities delivered by such Grantor pursuant to this Security Agreement, will be accompanied by duly executed undated blank stock powers, or other equivalent instruments of transfer reasonably acceptable to the Lender. 

  
 16 









 Exhibit 10.8 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 SECTION 4.1.4. Continuous Pledge. Each Grantor will (subject to the terms of the
Credit Agreement) (a) deliver to the Lender all Investment Property and all Payment Intangibles to the extent that such Investment Property or Payment Intangibles are evidenced by a Document, Instrument, Promissory Note or Chattel Paper (other
than any Document, Instrument, Promissory Note or Chattel Paper not exceeding $[***] in the principal amount), and (b) at all times keep pledged to the Lender pursuant hereto, on a first-priority,
perfected basis, security interest therein and in all interest and principal with respect to such Payment Intangibles, and all Proceeds and rights from time to time received by or distributable to such Grantor in respect of any of the foregoing
Collateral. Each Grantor agrees that it will, promptly following receipt thereof, deliver to the Lender possession of all originals of negotiable Documents, Instruments, Promissory Notes and Chattel Paper that it acquires following the Closing Date
(other than any Document, Instrument, Promissory Note or Chattel Paper not exceeding $[***] in the principal amount). 
 SECTION 4.1.5.
Voting Rights, Dividends, Etc. Each Grantor agrees: 
 (a) upon receipt of notice of the occurrence and continuance of
an Event of Default from the Lender and without any request therefor by the Lender, so long as such Event of Default shall continue, to deliver (properly endorsed where required hereby or requested by the Lender) to the Lender all dividends and
Distributions with respect to Investment Property, all interest, principal, other cash payments on Payment Intangibles, and all Proceeds of the Collateral, in each case thereafter received by such Grantor, all of which shall be held by the Lender as
additional Collateral, except for payments made in accordance with Section 8.6 of the Credit Agreement; and 
 (b)
immediately upon the occurrence and during the continuance of an Event of Default and so long as the Lender has notified such Grantor of the Lender’s intention to exercise its voting power under this clause, 

(i) with respect to Collateral consisting of general partner interests or limited liability company interests, to promptly
modify its Organic Documents to admit the Lender as a general partner or member, as applicable; 
 (ii) that the Lender may
exercise (to the exclusion of such Grantor) the voting power and all other incidental rights of ownership with respect to any Investment Property constituting Collateral and such Grantor hereby grants the Lender an irrevocable proxy, exercisable
under such circumstances, to vote such Investment Property; and 
 (iii) to promptly deliver to the Lender such additional
proxies and other documents as may be necessary to allow the Lender to exercise such voting power. 

  
 17 









 Exhibit 10.8 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 All dividends, Distributions, interest, principal, cash payments, Payment Intangibles and Proceeds that may
at any time and from time to time be held by such Grantor, but which such Grantor is then obligated to deliver to the Lender, shall, until delivery to the Lender, be held by such Grantor separate and apart from its other property in trust for the
Lender. The Lender agrees that unless an Event of Default shall have occurred and be continuing and the Lender shall have given the notice referred to in clause (b), such Grantor will have the exclusive voting power with respect to any
Investment Property constituting Collateral and the Lender will, upon the written request of such Grantor, promptly deliver such proxies and other documents, if any, as shall be reasonably requested by such Grantor which are necessary to allow such
Grantor to exercise that voting power; provided that no vote shall be cast, or consent, waiver, or ratification given, or action taken by such Grantor that would impair any such Collateral or be inconsistent with or violate any provision of
any Loan Document. 
 SECTION 4.2. Change of Name, Etc. No Grantor will change its name or place of incorporation or organization or
federal taxpayer identification number except as otherwise permitted by the Credit Agreement. 
 SECTION 4.3. As to Accounts. 

(a) Each Grantor shall have the right to collect all Accounts so long as no Event of Default shall have occurred and be
continuing. 
 (b) Upon (i) the occurrence and continuance of an Event of Default and (ii) the delivery of notice
by the Lender to each Grantor, all Proceeds of Collateral received by such Grantor shall be delivered in kind to the Lender for deposit in a Deposit Account of such Grantor maintained with the Lender (together with any other Deposit Accounts or
Security Accounts pursuant to which any portion of the Collateral is deposited with the Lender, the “Collateral Accounts”), and such Grantor shall not commingle any such Proceeds, and shall hold separate and apart from all other
property, all such Proceeds in express trust for the benefit of the Lender until delivery thereof is made to the Lender. 

(c) Following the delivery of notice pursuant to clause (b)(ii), the Lender shall have the right to apply any amount in
the Collateral Account to the payment of any Obligations which are then due and payable. 
 (d) With respect to each of the
Collateral Accounts, it is hereby confirmed and agreed that (i) deposits in such Collateral Account are subject to a security interest as contemplated hereby, (ii) such Collateral Account shall be under the control of the Lender and
(iii) the Lender shall have the sole right of withdrawal over such Collateral Account. 

  
 18 









 Exhibit 10.8 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 SECTION 4.4. As to Grantors’ Use of Collateral. 

(a) Subject to clause (b), each Grantor (i) may in the ordinary course of its business, at its own expense, sell, lease
or furnish under contracts of service any of the Inventory normally held by such Grantor for such purpose, and use and consume, in the ordinary course of its business, any raw materials, work in process or materials normally held by such Grantor for
such purpose, (ii) will, at its own expense, endeavor to collect, as and when due, all amounts due with respect to any of the Collateral, including the taking of such action with respect to such collection as the Lender may reasonably request
following the occurrence of an Event of Default or, in the absence of such request, as such Grantor may deem advisable, and (iii) may grant, in the ordinary course of business, to any party obligated on any of the Collateral, any rebate, refund or
allowance to which such party may be lawfully entitled, and may accept, in connection therewith, the return of Goods, the sale or lease of which shall have given rise to such Collateral. 

(b) At any time following the occurrence and during the continuance of an Event of Default, whether before or after the
maturity of any of the Obligations, the Lender may (i) revoke any or all of the rights of each Grantor set forth in clause (a), (ii) notify any parties obligated on any of the Collateral to make payment to the Lender of any amounts
due or to become due thereunder and (iii) enforce collection of any of the Collateral by suit or otherwise and surrender, release, or exchange all or any part thereof, or compromise or extend or renew for any period (whether or not longer than
the original period) any indebtedness thereunder or evidenced thereby. 
 (c) Upon the request of the Lender following the
occurrence and during the continuance of an Event of Default, each Grantor will, at its own expense, notify any parties obligated on any of the Collateral to make payment to the Lender of any amounts due or to become due thereunder. 

(d) At any time following the occurrence and during the continuation of an Event of Default, the Lender may endorse, in the
name of such Grantor, any item, howsoever received by the Lender, representing any payment on or other Proceeds of any of the Collateral. 

SECTION 4.5. As to Intellectual Property Collateral. Each Grantor covenants and agrees to comply with the following provisions as such
provisions relate to any Intellectual Property Collateral material to the operations or business of such Grantor: 

  
 19 









 Exhibit 10.8 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 (a) such Grantor will not (i) do or fail to perform any act whereby any
of the Patent Collateral may lapse or become abandoned or dedicated to the public or unenforceable, (ii) permit any of its licensees to (A) fail to continue to use any of the Trademark Collateral in order to maintain all of the Trademark
Collateral in full force free from any claim of abandonment for non-use, (B) fail to maintain the quality of products and services offered under all of the Trademark Collateral at a level substantially
consistent with the quality of products and services offered under such Trademark as of the date hereof, (C) fail to employ all of the Trademark Collateral registered with any federal or state or foreign authority with an appropriate notice of
such registration, (D) adopt or use any other Trademark which is confusingly similar or a colorable imitation of any of the Trademark Collateral, (E) use any of the Trademark Collateral registered with any federal, state or foreign
authority except for the uses for which registration or application for registration of all of the Trademark Collateral has been made or (F) do or permit any act or knowingly omit to do any act whereby any of the Trademark Collateral may become
invalid or unenforceable, or (iii) do or permit any act or knowingly omit to do any act whereby any of the Copyright Collateral or any of the Trade Secrets Collateral may lapse or become invalid or unenforceable or placed in the public domain
except upon expiration of the end of an unrenewable term of a registration thereof, unless, in the case of any of the foregoing requirements in clauses (i), (ii) and (iii), such Grantor reasonably and in good faith
determines that either (x) the further prosecution or maintenance of such Intellectual Property Collateral is not economically justified in relation to the economic value, or potential or expected economic value to such Grantor or any other
Credit Obligor, (y) the loss of such Intellectual Property Collateral would not be material to such Grantor or any other Credit Obligor or (z) the Grantor, in its reasonable judgment, determines that further prosecution of such
Intellectual Property Collateral is unlikely to result in an allowance of exclusive patent rights; 
 (b) such Grantor shall
promptly notify the Lender if it knows, or has reason to know, that any application or registration relating to any material item of the Intellectual Property Collateral may, in the Grantor’s reasonable commercial judgment, become abandoned or
dedicated to the public or placed in the public domain or invalid or unenforceable, or of any adverse determination or development (including the institution of, or any such determination or development in, any proceeding in the United States Patent
and Trademark Office, the United States Copyright Office or any foreign counterpart thereof or any court) regarding such Grantor’s ownership of any of the Intellectual Property Collateral, its right to register the same or to keep and maintain
and enforce the same; 
 (c) at the times and with such frequency set forth in Section 4.5(e) below, each Grantor shall
notify the Lender of the filing of an application for the registration of any Intellectual Property Collateral with the United States Patent and Trademark Office, the United States Copyright Office or any similar office or agency in any other
country or any political subdivision thereof by such Grantor or any of its agents, employees, designees or licensees, and, upon request of the Lender (subject to the terms of the Credit Agreement), executes and delivers all agreements, instruments
and documents as the Lender may reasonably request to evidence the Lender’s security interest in such Intellectual Property Collateral; 

  
 20 









 Exhibit 10.8 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 (d) such Grantor will take all reasonable and necessary steps, including in
any proceeding before the United States Patent and Trademark Office, the United States Copyright Office or any similar office or agency in any other country or any political subdivision thereof (subject to the terms of the Credit Agreement), to
maintain and pursue any material application (and to obtain the relevant registration) filed with respect to, and to maintain any registration of, material Intellectual Property Collateral, including the filing of applications for renewal,
affidavits of use, affidavits of incontestability and opposition, interference and cancellation proceedings and the payment of fees and taxes (except to the extent that dedication, abandonment or invalidation is permitted under the foregoing
clause (a) or (b) or such Grantor reasonably and in good faith determines that the failure to take any such step would not have a material adverse effect on the interests of the Lender in such Intellectual Property
Collateral); and 
 (e) such Grantor will within 45 days after the end of each Fiscal Quarter execute and deliver to the
Lender (as applicable) a Patent Security Agreement, Trademark Security Agreement and/or Copyright Security Agreement, as the case may be, in the forms of Exhibit A, Exhibit B and Exhibit C hereto following its obtaining an
interest in any such Intellectual Property or such Grantor filing (or any of its agents, employees, designees or licensees filing on behalf of a Grantor) an application for the registration of any Intellectual Property Collateral in accordance with
Section 4.5(c) above, and shall execute and deliver to the Lender any other document reasonably required to evidence the Lender’s interest in any part of such item of Intellectual Property Collateral unless such Grantor shall determine in
good faith (with the consent of the Lender) that any Intellectual Property Collateral is of negligible economic value to such Grantor. 

SECTION 4.6. As to Letter-of-Credit Rights. 

(a) Each Grantor, by granting a security interest in its Letter-of-Credit Rights to the Lender, intends to (and hereby does)
collaterally assign to the Lender its rights (including its contingent rights ) to the Proceeds of all Letter-of-Credit Rights of which it is or hereafter becomes a beneficiary or assignee. 

(b) Upon the occurrence of an Event of Default, such Grantor will, promptly upon request by the Lender, (i) notify (and
such Grantor hereby authorizes the Lender to notify) the issuer and each nominated person with respect to each of the Letters of Credit that the Proceeds thereof have been assigned to the Lender hereunder and any payments due or to become due in
respect thereof are to be made directly to the Lender and (ii) arrange for the Lender to become the transferee beneficiary of such Letter of Credit. 

  
 21 









 Exhibit 10.8 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 SECTION 4.7. As to Commercial Tort Claims. Each Grantor covenants and agrees that,
until the payment in full of the Obligations and termination of all Commitments, with respect to any Commercial Tort Claim hereafter arising, it shall deliver to the Lender a supplement in form and substance reasonably satisfactory to the Lender,
together with all supplements to schedules thereto, identifying such new Commercial Tort Claim. 
 SECTION 4.8. Electronic Chattel Paper
and Transferable Records. If any Grantor at any time holds or acquires an interest in any electronic chattel paper or any “transferable record,” as that term is defined in Section 201 of the U.S. Federal Electronic Signatures in
Global and National Commerce Act, or in Section 16 of the U.S. Uniform Electronic Transactions Act as in effect in any relevant jurisdiction, with a value in excess of $[***], such Grantor shall promptly notify the Lender thereof and, at the
request of the Lender, shall take such action as the Lender may reasonably request to vest in the Lender control under Section 9-105 of the UCC of such electronic chattel paper or control under Section 201 of the Federal Electronic
Signatures in Global and National Commerce Act or, as the case may be, Section 16 of the Uniform Electronic Transactions Act, as so in effect in such jurisdiction, of such transferable record. The Lender agrees with such Grantor that the Lender
will arrange, pursuant to procedures satisfactory to the Lender and so long as such procedures will not result in the Lender’s loss of control, for the Grantor to make alterations to the electronic chattel paper or transferable record permitted
under Section 9-105 of the UCC or, as the case may be, Section 201 of the U.S. Federal Electronic Signatures in Global and National Commerce Act or Section 16 of the U.S. Uniform Electronic Transactions Act for a party in control to
allow without loss of control, unless an Event of Default has occurred and is continuing or would occur after taking into account any action by such Grantor with respect to such electronic chattel paper or transferable record. 

SECTION 4.9. Further Assurances, Etc. Each Grantor agrees that, from time to time at its own expense, it will, subject to the terms of
this Security Agreement, promptly execute and deliver all further instruments and documents, and take all further action, that may be necessary or that the Lender may reasonably request, in order to perfect, preserve and protect any security
interest granted or purported to be granted hereby or to enable the Lender to exercise and enforce its rights and remedies hereunder with respect to any Collateral. Without limiting the generality of the foregoing, such Grantor will 

(a) from time to time upon the request of the Lender, promptly deliver to the Lender such stock powers, instruments and similar
documents, reasonably satisfactory in form and substance to the Lender, with respect to such Collateral as the Lender may request and will, from time to time upon the request of the Lender, after the occurrence and during the continuance of any
Event of Default, promptly transfer any securities constituting Collateral into the name of any nominee designated by the Lender; if any 

  
 22 









 Exhibit 10.8 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 
Collateral shall be evidenced by an Instrument, negotiable Document, Promissory Note or tangible Chattel Paper, deliver and pledge to the Lender hereunder such Instrument, negotiable Document,
Promissory Note or tangible Chattel Paper (other than any Instrument, negotiable Document, Promissory Note or tangible Chattel Paper in principal amount less than $[***]) duly endorsed and accompanied by duly executed instruments of transfer or
assignment, all in form and substance reasonably satisfactory to the Lender; 
 (b) file (and hereby authorizes the Lender to
file) such Filing Statements or continuation statements, or amendments thereto, and such other instruments or notices (including any assignment of claim form under or pursuant to the federal assignment of claims statute, 31 U.S.C. § 3726, any
successor or amended version thereof or any regulation promulgated under or pursuant to any version thereof), as may be necessary or that the Lender may reasonably request in order to perfect and preserve the security interests and other rights
granted or purported to be granted to the Lender hereby; 
 (c) at all times keep pledged to the Lender pursuant hereto, on a
first-priority, perfected basis, at the request of the Lender, all Investment Property constituting Collateral, all dividends and Distributions with respect thereto, and all interest and principal with respect
to Promissory Notes, and all Proceeds and rights from time to time received by or distributable to such Grantor in respect of any of the foregoing Collateral; 

(d) not take or omit to take any action the taking or the omission of which would result in any impairment or alteration of any
obligation of the maker of any Payment Intangible or other Instrument constituting Collateral, except as provided in Section 4.4; 

(e) not create any tangible Chattel Paper without placing a legend on such tangible Chattel Paper reasonably acceptable to the
Lender indicating that the Lender has a security interest in such Chattel Paper (provided that so long as no Event of Default is continuing, Chattel Paper and records relating to such Collateral for amounts in each case less than $[***], need only
be marked upon Lender’s request); 
 (f) furnish to the Lender, from time to time at the Lender’s request,
statements and schedules further identifying and describing the Collateral and such other reports in connection with the Collateral (including any real property locations where material Collateral Records or Collateral in excess of $[***] in
aggregate are located) as the Lender may request, all in reasonable detail (provided however, for so long as no Event of Default has occurred, Lender may not require such additional statements and schedules more than once per fiscal quarter); and


  
 23 









 Exhibit 10.8 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 (g) do all things reasonably requested by the Lender in accordance with this
Security Agreement (including dollar thresholds herein) in order to enable the Lender to have and maintain control over the Collateral consisting of Investment Property, Deposit Accounts, Letter-of-Credit-Rights and Electronic Chattel Paper. 

With respect to the foregoing and the grant of the security interest hereunder, each Grantor hereby authorizes the Lender to file one or more
financing or continuation statements, and amendments thereto, relative to all or any part of the Collateral. Each Grantor agrees that a carbon, photographic or other reproduction of this Security Agreement or any UCC financing statement covering the
Collateral or any part thereof shall be sufficient as a UCC financing statement where permitted by law. Each Grantor hereby authorizes the Lender to file financing statements describing as the collateral covered thereby “all of the
debtor’s personal property or assets” or words to that effect, notwithstanding that such wording may be broader in scope than the Collateral described in this Security Agreement. Each Grantor also agrees to promptly notify the Lender of
any change in the location of any office in which it maintains Collateral Records or any office or facility at which Collateral is located (including the establishment of any such new office or facility). 

ARTICLE V 
 THE LENDER 

SECTION 5.1. Lender Appointed Attorney-in-Fact. Each
Grantor hereby irrevocably appoints the Lender as its attorney-in-fact, with full authority in the place and stead of such Grantor and in the name of such Grantor or
otherwise, from time to time in the Lender’s discretion, following the occurrence and during the continuance of an Event of Default, to take any action and to execute any instrument which the Lender may deem necessary or advisable to accomplish
the purposes of this Security Agreement, including: 
 (a) to ask, demand, collect, sue for, recover, compromise, receive and
give acquittance and receipts for moneys due and to become due under or in respect of any of the Collateral; 
 (b) to
receive, endorse, and collect any drafts or other Instruments, Documents and Chattel Paper, in connection with clause (a) above; and 

(c) to file any claims or take any action or institute any proceedings which the Lender may deem necessary or desirable for the
collection of any of the Collateral or otherwise to enforce the rights of the Lender with respect to any of the Collateral. 
 Each Grantor hereby
acknowledges, consents and agrees that the power of attorney granted pursuant to this Section is irrevocable and coupled with an interest. 

  
 24 









 Exhibit 10.8 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 SECTION 5.2. Lender May Perform. If any Grantor fails to perform any agreement
contained herein, the Lender may itself perform, or cause performance of, such agreement, that the Lender deems necessary for the maintenance, preservation or protection of any of the Collateral or of its security interest therein to the extent
provided for herein, and the expenses of the Lender incurred in connection therewith shall be payable by such Grantor pursuant to Section 10.3 of the Credit Agreement. 

SECTION 5.3. Lender Has No Duty. The powers conferred on the Lender hereunder are solely to protect its interest in the Collateral and
shall not impose any duty on it to exercise any such powers. Except for reasonable care of any Collateral in its possession and the accounting for moneys actually received by it hereunder, the Lender shall have no duty as to any Collateral or
responsibility for 
 (a) ascertaining or taking action with respect to calls, conversions, exchanges, maturities, tenders or
other matters relative to any Investment Property, whether or not the Lender has or is deemed to have knowledge of such matters, or 

(b) taking any necessary steps to preserve rights against prior parties or any other rights pertaining to any Collateral. 

SECTION 5.4. Reasonable Care. The Lender is required to exercise reasonable care in the custody and preservation of any of the
Collateral in its possession; provided that the Lender shall be deemed to have exercised reasonable care in the custody and preservation of any of the Collateral, if it takes such action for that purpose as each Grantor reasonably requests in
writing at times other than upon the occurrence and during the continuance of any Event of Default, but failure of the Lender to comply with any such request at any time shall not in itself be deemed a failure to exercise reasonable care. 

SECTION 5.5. Lender as Agent for Other Secured Parties. 

(a) Each of the Lender and ROS hereby irrevocably appoints the Lender hereunder and under the other Loan Documents as its agent
and authorizes the Lender to take such actions on its behalf as collateral agent for all purposes hereunder and under the other Loan Documents pursuant to which any Grantor grants a Lien or other right in any collateral (including Collateral and any
“Collateral” howsoever described in any Australian Security Document)to secure the Obligations and for purposes of acquiring, holding and enforcing any and all Liens on any collateral (including Collateral and any “Collateral”
howsoever described in any Australian Security Document) granted by any Grantor to secure any of the Obligations, including execution of the other Loan Documents, and to exercise such powers as are delegated to the Lender by the terms of the Loan
Documents, together with such actions and powers as are reasonably incidental thereto. The provisions of this Section are solely for the benefit of the Lender and ROS, and no Grantor shall have rights as a third-party beneficiary of any of such
provisions. 

  
 25 









 Exhibit 10.8 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 (b) The Person serving as the collateral agent shall have the same rights and
powers in its capacity as the Lender under the Credit Agreement and may exercise the same as though it were not the collateral agent. The Lender shall not have any duties or obligations except those expressly set forth in the Loan Documents, and its
duties thereunder shall be administrative in nature. The Lender shall not be liable for any action taken or not taken by it with the consent or at the request of ROS or in the absence of its own gross negligence or willful misconduct as determined
by a court of competent jurisdiction by final and nonappealable judgment. The Lender may appoint any co-agents, sub-agents or attorneys-in-fact in connection with the foregoing. 

(c) The Lender shall be entitled to rely upon, and shall not incur any liability for relying upon, any notice, request,
certificate, consent, statement, instrument, document or other writing (including any electronic message, Internet or intranet website posting or other distribution) believed by it to be genuine and to have been signed, sent or otherwise
authenticated by the proper Person. The Lender also may rely upon any statement made to it orally (including by telephone) and believed by it to have been made by the proper Person, and shall not incur any liability for relying thereon. The Lender
may consult with legal counsel, independent accountants and other experts selected by it, and shall not be liable for any action taken or not taken by it in accordance with the advice of any such counsel, accountants or experts. If in accordance
with the terms of the applicable Loan Documents, any additional Person is assigned, granted or otherwise transferred all or any portion of the Obligations under the Loan Documents (each such new Person, an “Additional Secured Party”
and collectively, the “Additional Secured Parties”), such Additional Secured Party shall preserve all of its rights with respect to the security interests and Lien created pursuant to this Agreement, so that the security created by
hereunder shall be automatically transferred to the assignee, transferee or new creditor after novation. Notwithstanding the foregoing, each Additional Secured Party shall deliver a counterpart signature page to this Agreement and accept and
acknowledge its rights, duties and obligations as if it were a Secured Party to this Agreement as of the Closing Date (including the appointment of the Lender to act as its agent for the purposes of perfecting and maintaining the security interest
in the Collateral on its behalf). On and after the delivery of a counterpart signature page to this Agreement by an Additional Secured Party, all references in this Agreement or in the other Loan Documents to the secured parties in reference to the
Obligations shall mean, be and include a reference to such Additional Secured Party. 

  
 26 









 Exhibit 10.8 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 ARTICLE VI 

REMEDIES 
 SECTION 6.1. Certain
Remedies. If any Event of Default shall have occurred and be continuing: 
 (a) The Lender may exercise in respect of the
Collateral, in addition to other rights and remedies provided for herein or otherwise available to it, all the rights and remedies of the Lender on default under the UCC (whether or not the UCC applies to the affected Collateral) and also may 

(i) take possession of any Collateral not already in its possession without demand and without legal process; 

(ii) require each Grantor to, and each Grantor hereby agrees that it will, at its expense and upon request of the Lender
forthwith, assemble all or part of the Collateral as directed by the Lender and make it available to the Lender at a place to be designated by the Lender that is reasonably convenient to both parties, 

(iii) enter onto the property where any Collateral is located and take possession thereof without demand and without legal
process; and 
 (iv) without notice except as specified below, lease, license, sell or otherwise dispose of the Collateral or
any part thereof in one or more parcels at any public or private sale, at any of the Lender’s offices or elsewhere, for cash, on credit or for future delivery, and upon such other terms as the Lender may deem commercially reasonable. Each
Grantor agrees that, to the extent notice of sale shall be required by law, at least ten (10) days’ prior notice to such Grantor of the time and place of any public sale or the time after which any private sale is to be made shall
constitute reasonable notification. The Lender shall not be obligated to make any sale of Collateral regardless of notice of sale having been given. The Lender may adjourn any public or private sale from time to time by announcement at the time and
place fixed therefor, and such sale may, without further notice, be made at the time and place to which it was so adjourned. 

(b) All cash Proceeds received by the Lender in respect of any sale of, collection from, or other realization upon, all or any
part of the Collateral shall be applied by the Lender against all or any part of the Obligations as set forth in Section 4.4(b) of the Credit Agreement. 

(c) The Lender may: 

(i) transfer all or any part of the Collateral into the name of the Lender or its nominee, with or without disclosing that such
Collateral is subject to the Lien hereunder, 
 (ii) notify the parties obligated on any of the Collateral to make payment to
the Lender of any amount due or to become due thereunder, 

  
 27 









 Exhibit 10.8 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 (iii) withdraw, or cause or direct the withdrawal, of all funds with respect
to the Collateral Account; 
 (iv) enforce collection of any of the Collateral by suit or otherwise, and surrender, release
or exchange all or any part thereof, or compromise or extend or renew for any period (whether or not longer than the original period) any obligations of any nature of any party with respect thereto, 

(v) endorse any checks, drafts, or other writings in any Grantor’s name to allow collection of the Collateral, 

(vi) take control of any Proceeds of the Collateral, and 

(vii) execute (in the name, place and stead of any Grantor) endorsements, assignments, stock powers and other instruments of
conveyance or transfer with respect to all or any of the Collateral. 
 SECTION 6.2. Securities Laws. If the Lender shall determine
to exercise its right to sell all or any of the Collateral that are Capital Securities pursuant to Section 6.1(a)(iv), each Grantor agrees that, upon request of the Lender, such Grantor will, at its own expense: 

(a) execute and deliver, and cause (or, with respect to any issuer which is not a Subsidiary of such Grantor, use its best
efforts to cause) each issuer of the Collateral contemplated to be sold and the directors and officers thereof to execute and deliver, all such instruments and documents, and do or cause to be done all such other acts and things, as may be necessary
or, in the opinion of the Lender, advisable to register such Collateral under the provisions of the Securities Act of 1933, as from time to time amended (the “Securities Act”), and cause the registration statement relating thereto
to become effective and to remain effective for such period as prospectuses are required by law to be furnished, and to make all amendments and supplements thereto and to the related prospectus which, in the opinion of the Lender, are necessary or
advisable, all in conformity with the requirements of the Securities Act and the rules and regulations of the SEC applicable thereto; 

(b) use its best efforts to exempt the Collateral under the state securities or “Blue Sky” laws and to obtain all
necessary governmental approvals for the sale of the Collateral, as requested by the Lender; 
 (c) cause (or, with respect
to any issuer that is not a Subsidiary of such Grantor, use its best efforts to cause) each such issuer to make available to its security holders, as soon as practicable, an earnings statement that will satisfy the provisions of Section 11(a)
of the Securities Act; and 

  
 28 









 Exhibit 10.8 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 (d) do or cause to be done all such other acts and things as may be necessary
to make such sale of the Collateral or any part thereof valid and binding and in compliance with applicable law. 
 Each Grantor acknowledges the
impossibility of ascertaining the amount of damages that would be suffered by the Lender by reason of the failure by such Grantor to perform any of the covenants contained in this Section and consequently agrees, to the fullest extent permitted by
applicable law, that, if such Grantor shall fail to perform any of such covenants, it shall pay, as liquidated damages and not as a penalty, an amount equal to the value (as determined by the Lender) of such Collateral on the date the Lender shall
demand compliance with this Section. 
 SECTION 6.3. Compliance with Restrictions. Each Grantor agrees that in any sale of any of the
Collateral whenever an Event of Default shall have occurred and be continuing, the Lender is hereby authorized to comply with any limitation or restriction in connection with such sale as it may be advised by counsel is necessary in order to avoid
any violation of applicable law (including compliance with such procedures as may restrict the number of prospective bidders and purchasers, require that such prospective bidders and purchasers have certain qualifications, and restrict such
prospective bidders and purchasers to Persons who will represent and agree that they are purchasing for their own account for investment and not with a view to the distribution or resale of such Collateral), or in order to obtain any required
approval of the sale or of the purchaser by any Governmental Authority or official, and such Grantor further agrees that such compliance shall not result in such sale being considered or deemed not to have been made in a commercially reasonable
manner, nor shall the Lender be liable nor accountable to such Grantor for any discount allowed by the reason of the fact that such Collateral is sold in compliance with any such limitation or restriction. 

SECTION 6.4. Protection of Collateral. The Lender may from time to time, at its option, perform any act which any Grantor fails to
perform after being requested in writing so to perform (it being understood that no such request need be given after the occurrence and during the continuance of an Event of Default) and the Lender may from time to time take any other action which
the Lender deems necessary for the maintenance, preservation or protection of any of the Collateral or of its security interest therein. 

ARTICLE VII 
 MISCELLANEOUS
PROVISIONS 
 SECTION 7.1. Loan Document. This Security Agreement is a Loan Document executed pursuant to the Credit Agreement and
shall (unless otherwise expressly indicated herein) be construed, administered and applied in accordance with the terms and provisions thereof, including Article X thereof. 

  
 29 









 Exhibit 10.8 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 SECTION 7.2. Binding on Successors, Transferees and Assigns; Assignment. This Security
Agreement shall remain in full force and effect until the Termination Date has occurred, shall be binding upon the Grantors and their successors, transferees and assigns and shall inure to the benefit of and be enforceable by the Lender;
provided that no Grantor may assign any of its obligations hereunder without the prior consent of the Lender. 
 SECTION 7.3.
Amendments, Etc. No amendment or modification to or waiver of any provision of this Security Agreement, nor consent to any departure by any Grantor from its obligations under this Security Agreement, shall in any event be effective unless the
same shall be in writing and signed by the Lender and the Grantors and then such waiver or consent shall be effective only in the specific instance and for the specific purpose for which given. 

SECTION 7.4. Notices. All notices and other communications provided for hereunder shall be delivered or made as provided in
Section 10.2 of the Credit Agreement. 
 SECTION 7.5. Release of Liens. Upon (a) the Disposition of Collateral in
accordance with the Credit Agreement or (b) the occurrence of the Termination Date, the security interests granted herein shall automatically terminate with respect to (i) such Collateral (in the case of clause (a)) or (ii) all
Collateral (in the case of clause (b)). Upon any such Disposition or termination, the Lender will, at the Grantors’ sole expense, deliver to the Grantors, without any representations, warranties or recourse of any kind whatsoever, all
Collateral held by the Lender hereunder, and execute and deliver to the Grantors such documents as the Grantors shall reasonably request to evidence such termination. 

SECTION 7.6. Additional Grantors. Upon the execution and delivery by any other Person of a supplement in the form of Annex I
hereto, such Person shall become a “Grantor” hereunder with the same force and effect as if it were originally a party to this Security Agreement and named as a “Grantor” hereunder. The execution and delivery of such supplement
shall not require the consent of any other Grantor hereunder, and the rights and obligations of each Grantor hereunder shall remain in full force and effect notwithstanding the addition of any new Grantor as a party to this Security Agreement. 

SECTION 7.7. No Waiver, Remedies. In addition to, and not in limitation of Section 2.4, no failure on the part of the
Lender to exercise, and no delay in exercising, any right hereunder shall operate as a waiver thereof, nor shall any single or partial exercise of any right hereunder preclude any other or further exercise thereof or the exercise of any other right.
The remedies herein provided are cumulative and not exclusive of any remedies provided by law. 
 SECTION 7.8. Severability. Any
provision of this Security Agreement which is prohibited or unenforceable in any jurisdiction shall, as to such provision and such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining
provisions of this Security Agreement or affecting the validity or enforceability of such provision in any other jurisdiction. 

  
 30 









 Exhibit 10.8 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 SECTION 7.9. Governing Law, Entire Agreement, Etc. THIS SECURITY AGREEMENT AND ANY
CLAIMS, CONTROVERSY, DISPUTE OR CAUSE OF ACTION (WHETHER IN CONTRACT OR TORT OR OTHERWISE) BASED UPON, ARISING OUT OF OR RELATING TO THIS SECURITY AGREEMENT OR ANY DOCUMENT CONTEMPLATED HEREBY SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH,
THE INTERNAL LAWS OF THE STATE OF NEW YORK (INCLUDING FOR SUCH PURPOSE SECTIONS 5-1401 AND 5-1402 OF THE GENERAL OBLIGATIONS LAW OF THE STATE OF NEW YORK). This Security Agreement, along with the other Loan Documents, constitutes the entire
understanding among the parties hereto with respect to the subject matter thereof and supersedes any prior agreements, written or oral, with respect thereto 

SECTION 7.10. Counterparts. This Security Agreement may be executed by the parties hereto in several counterparts, each of which shall
be an original and all of which shall constitute together but one and the same agreement. This Security Agreement shall become effective when counterparts hereof executed on behalf of all of the signatories hereto, shall have been received by the
Lender. Delivery of an executed counterpart of a signature page to this Security Agreement by email (e.g. “pdf” or “tiff”) or telecopy shall be effective as delivery of a manually executed counterpart of this Security Agreement.

 SECTION 7.11. Australian Subsidiaries. Notwithstanding anything to the contrary herein, nothing herein shall apply to any
Collateral owned by an Australian Subsidiary and not located in the United States or any state or territory thereof (including the District of Columbia) or created pursuant to or governed by any United States federal law or the laws of state or
territory thereof (including the District of Columbia) (it being understood that all Intellectual Property (regardless of where registered), other than Intellectual Property registered in Australia, is deemed located in the United States for
purposes of this paragraph), which is in the subject of the General Security Deed executed by Holdings and the Australian Subsidiaries in favor of Lender and not this Agreement. 

[Signature Page Follows] 

  
 31 









 Exhibit 10.8 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 IN WITNESS WHEREOF, each of the parties hereto has caused this Security Agreement to be duly
executed and delivered by its Authorized Officer as of the date first above written. 
  

EXECUTED as a deed by each Australian Subsidiary. 
  

											
	UNILIFE MEDICAL SOLUTIONS, INC.	 		 	UNILIFE CORPORATION	 	
						
	By:	 	/s/ Alan Shortall	 		 	By:	 	/s/ Alan Shortall	 	
		 	Name: Alan Shortall	 		 		 	Name: Alan Shortall	 	
		 	Title: Chairman and CEO	 		 		 	Title: Chairman and CEO	 	
					
		 		 		 	UNILIFE CROSS FARM LLC	 	
						
		 		 		 	By:	 	 /s/ Alan Shortall
	 	
		 		 		 		 	Name: Alan Shortall	 	
		 		 		 		 	Title: Chairman and CEO	 	
	Executed by Unilife Medical Solutions Pty Limited in accordance with Section 127 of the Corporations Act 2001	 		 		 	
				
	     /s/ Alan Shortall
	 		 	 /s/ Ramin Mojdehbakhsh
	 	
	 Signature of director
	 		 	 Signature of director/company secretary

(Please delete as applicable)
	 	
		 		 		 	
				
	     Alan Shortall
	 		 	 Ramin Mojdehbakhsh
	 	
	 Name of director (print)
	 		 	Name of director/company secretary (print)	 	

 Signature Page to Security Agreement 

  









 Exhibit 10.8 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  


											
	 Executed by Unitract Syringe Pty Ltd in

accordance with Section 127 of the
 Corporations Act
2001
	 		 		 		 	
				
	     /s/ Alan Shortall
	 		 	     /s/ Ramin Mojdehbakhsh
	 	
	Signature of director	 		 	 Signature of director/company secretary

(Please delete as applicable)
	 	
				
	     Alan Shortall
	 		 	     Ramin Mojdehbakhsh
	 	
	Name of director (print)	 		 	Name of director/company secretary (print)	 	

 Signature Page to Security Agreement 

  









 Exhibit 10.8 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 
			
	ROS ACQUISITION OFFSHORE LP,
	as the Lender, for itself and as agent
	By OrbiMed Advisors LLC, its investment manager
		
	By:	 	 /s/ Sven Borho

		 	Name: Sven Borho
		 	Title: Managing Member
	
	 ROYALTY OPPORTUNITIES S.À R.L,

as Secured Party

	
	By OrbiMed Advisors LLC, its investment manager
		
	By:	 	 /s/ Sven Borho

		 	Name: Sven Borho
		 	Title: Managing Member


 Signature Page to Security Agreement 

  









 Exhibit 10.8 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 SCHEDULE I 

to Security Agreement 
  

					
	Name of Grantor:	  	Interest:	  	

 Signature Page to Security Agreement 

  









 Exhibit 10.8 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 SCHEDULE II 

to Security Agreement 
 Item A. Location of each
Grantor. 
  

					
	 Name of Grantor:
	  	 Location for purposes of UCC:
	  	 Address of executive office and

principal place of business:


 Item B. Filing
locations last five years. 
 Item C. Trade names. 
  

			
	 Name of Grantor:
	  	 Trade Names:



Item D. Merger or other corporate reorganization. 
 Item
E. Grantor’s federal taxpayer ID numbers. 
  

			
	 Name of Grantor:
	  	 Taxpayer ID numbers:



Item F. Government Contracts. 
 Item G. Deposit
Accounts, Securities Accounts and Commodities Accounts. 
  

			
	 Name of Grantor:
	  	 Description of Deposit Accounts, Securities Accounts and

Commodities Accounts:


 Item H. Letter of
Credit Rights. 

  









 Exhibit 10.8 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 Item I. Commercial Tort Claims. 

Item J. Pledged Notes. 
  

			
	 Name of Grantor:
	  	 Description of Pledged Notes:



  









 Exhibit 10.8 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 SCHEDULE III 

to Security Agreement 
 Item A. Patents 

Item B. Patent Licenses 

  









 Exhibit 10.8 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 SCHEDULE IV 

to Security Agreement 
 Item A. Trademarks

 Item B. Trademark Licenses 

  









 Exhibit 10.8 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 SCHEDULE V 

to Security Agreement 
 Item A. Copyrights/Mask
Works 
 Item B. Copyright/Mask Work Licenses 

  









 Exhibit 10.8 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 SCHEDULE VI 

to Security Agreement 
 Trade
Secret or Know-How Licenses 
 Pledge and Security Agreement 

  
 41 









 Exhibit 10.8 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 EXHIBIT A 

to Security Agreement 
 PATENT
SECURITY AGREEMENT 
 This PATENT SECURITY AGREEMENT, dated as of
                 , 20     (this “Agreement”), is made by [NAME OF GRANTOR], a
                     (the “Grantor”), in favor of ROS ACQUISITION OFFSHORE LP, a Cayman Islands exempted limited partnership, for
itself and as agent for the other parties to which the Grantor may owe any Obligations (together with its Affiliates, successors, transferees and assignees, the “Lender”). 

W I T N E S S E T H : 

WHEREAS, pursuant to a Credit Agreement, dated as of [            ], 2014 (as
amended, supplemented or otherwise modified from time to time, the “Credit Agreement”), by and between Unilife Medical Solutions, Inc., a Delaware corporation (the “Borrower”) and the Lender, the Lender has extended
a Commitment to make the Loans to the Borrower; 
 WHEREAS, in connection with the Credit Agreement, the Grantor and its Affiliates have
executed and delivered a Pledge and Security Agreement in favor of the Lender, dated as of [            ], 2014 (as amended, supplemented or otherwise modified from time to time, the
“Security Agreement”); 
 WHEREAS, pursuant to the Credit Agreement and pursuant to clause (e) of Section 4.5 of
the Security Agreement, the Grantor is required to execute and deliver this Agreement and to grant to the Lender a continuing security interest in all of the Patent Collateral (as defined below) to secure all of the Obligations; and 

WHEREAS, the Grantor has duly authorized the execution, delivery and performance of this Agreement; 

NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Grantor agrees, for the
benefit of the Lender, as follows: 

  
 1 









 Exhibit 10.8 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 SECTION 1. Definitions. Unless otherwise defined herein or the context otherwise
requires, terms used in this Agreement, including its preamble and recitals, have the meanings provided (or incorporated by reference) in the Security Agreement. 

SECTION 2. Grant of Security Interest. The Grantor hereby grants to the Lender, for its benefit, a continuing security interest in all
of the Grantor’s right, title and interest in and to the following property, whether now or hereafter existing or acquired by the Grantor (the “Patent Collateral”): 

(a) all of its letters patent and applications for letters patent throughout the world, including each patent and patent
application referred to in Item A of Schedule I attached hereto; 
 (b) all reissues, divisions, continuations,
continuations-in-part, extensions, renewals and reexaminations of any of the items described in clause (a); 

(c) all patent licenses and other agreements providing the Grantor with the right to use any items of the type referred to
in clauses (a) and (b) above, including each patent license referred to in Item B of Schedule I attached hereto; and 

(d) all Proceeds of, and rights associated with, the foregoing (including licenses, royalties income, payments, claims, damages
and Proceeds of infringement suits) and the right to sue third parties for past, present or future infringements of any patent or patent application and for breach or enforcement of any patent license. 

SECTION 3. Security Agreement. This Agreement has been executed and delivered by the Grantor for the purpose of registering the
security interest of the Lender in the Patent Collateral with the United States Patent and Trademark Office. The security interest granted hereby has been granted in furtherance of, and not in limitation of, the security interest granted to the
Lender for its benefit under the Security Agreement. The Security Agreement (and all rights and remedies of the Lender thereunder) shall remain in full force and effect in accordance with its terms. 

SECTION 4. Release of Liens. Upon (i) the Disposition of Patent Collateral in accordance with the Credit Agreement or
(ii) the occurrence of the Termination Date, the security interests granted herein shall automatically terminate with respect to (A) such Patent Collateral (in the case of clause (i)) or (B) all Patent Collateral (in the case
of clause (ii)). Upon any such Disposition or termination, the Lender will, at the Grantor’s sole expense, deliver to the Grantor, without any representations, warranties or recourse of any kind whatsoever, all Patent Collateral held by
the Lender hereunder, and execute and deliver to the Grantor such documents as the Grantor shall reasonably request to evidence such termination. 

  
 2 









 Exhibit 10.8 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 SECTION 5. Acknowledgment. The Grantor does hereby further acknowledge and affirm that
the rights and remedies of the Lender with respect to the security interest in the Patent Collateral granted hereby are more fully set forth in the Security Agreement, the terms and provisions of which (including the remedies provided for therein)
are incorporated by reference herein as if fully set forth herein. 
 SECTION 6. Loan Document. This Agreement is a Loan Document
executed pursuant to the Credit Agreement and shall (unless otherwise expressly indicated herein) be construed, administered and applied in accordance with the terms and provisions thereof, including Article X thereof. 

SECTION 7. Effective. This Agreement shall become effective when a counterpart hereof executed by the Grantor, shall have been received
by the Lender. Delivery of an executed counterpart of a signature page to this Agreement by email (e.g. “pdf” or “tiff”) or telecopy shall be effective as delivery of a manually executed counterpart of this Agreement. 

[Signature Page Follows] 

  
 3 









 Exhibit 10.8 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 IN WITNESS WHEREOF, the Grantor hereto has caused this Agreement to be duly executed and
delivered by its Authorized Officer as of the date first above written. 
  

			
	[NAME OF GRANTOR]
		
	By:	 	  

		 	Name:
		 	Title:



  
 4 









 Exhibit 10.8 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 SCHEDULE I 

to Patent Security Agreement 
 Item A.
Patents 
  
  

									
	Issued Patents	  		  		  	
					
	 Country
	  	 Patent No.
	  	 Issue Date
	  	 Inventor(s)
	  	 Title


 Pending Patent Applications 
  

									
	 Country
	  	 Serial No.
	  	 Filing Date
	  	 Inventor(s)
	  	 Title



Patent Applications in Preparation 
  

									
	 	  	 	  	Expected	  	 	  	 
	 Country
	  	 Docket No.
	  	 Filing Date
	  	 Inventor(s)
	  	 Title



Item B. Patent Licenses 
  

											
	Country or	  	 	  	 	  	Effective	  	Expiration	  	Subject
	 Territory
	  	 Licensor
	  	 Licensee
	  	 Date
	  	 Date
	  	 Matter



  
 1 









 Exhibit 10.8 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 EXHIBIT B 

to Security Agreement 
 TRADEMARK
SECURITY AGREEMENT 
 This TRADEMARK SECURITY AGREEMENT, dated as of
                 , 20     (this “Agreement”), is made by [NAME OF GRANTOR], a
                    (the “Grantor”), in favor of ROS ACQUISITION OFFSHORE LP, a Cayman Islands exempted limited partnership, for
itself and as agent for the other parties to which the Grantor may owe any Obligations (together with its Affiliates, successors, transferees and assignees, the “Lender”). 

W I T N E S S E T H : 

WHEREAS, pursuant to a Credit Agreement, dated as of [            ], 2014 (as
amended, supplemented, or otherwise modified from time to time, the “Credit Agreement”), by and between Unilife Medical Solutions, Inc., a Delaware corporation (the “Borrower”) and the Lender, the Lender has
extended a Commitment to make the Loans to the Borrower; 
 WHEREAS, in connection with the Credit Agreement, the Grantor and its Affiliates
have executed and delivered a Pledge and Security Agreement in favor of the Lender, dated as of [            ], 2014 (as amended, supplemented, or otherwise modified from time to time, the
“Security Agreement”); 
 WHEREAS, pursuant to the Credit Agreement and pursuant to clause (e) of Section 4.5 of
the Security Agreement, the Grantor is required to execute and deliver this Agreement and to grant to the Lender a continuing security interest in all of the Trademark Collateral (as defined below) to secure all of the Obligations; and 

WHEREAS, the Grantor has duly authorized the execution, delivery and performance of this Agreement; 

NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Grantor agrees, for the
benefit of each Lender, as follows: 
 SECTION 1. Definitions. Unless otherwise defined herein or the context otherwise requires,
terms used in this Agreement, including its preamble and recitals, have the meanings provided (or incorporated by reference) in the Security Agreement. 

SECTION 2. Grant of Security Interest. The Grantor hereby grants to the Lender, for its benefit, a continuing security interest in all
of Grantor’s right, title and interest in and to the following property, whether now or hereafter existing or acquired by the Grantor (the “Trademark Collateral”): 

  
 1 









 Exhibit 10.8 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 (a) (i) all of its trademarks, trade names, corporate names, company
names, business names, fictitious business names, trade styles, service marks, certification marks, collective marks, logos and other source or business identifiers, and all goodwill of the business associated therewith, including those referred to
in Item A of Schedule I hereto, whether currently in use or not, all registrations and recordings thereof and all applications in connection therewith, whether pending or filed, including registrations, recordings and applications in
the United States Patent and Trademark Office or in any office or agency of the United States of America or any State thereof, and all common-law rights relating to the foregoing, and (ii) the right to
obtain all reissues, extensions or renewals of the foregoing (collectively referred to as the “Trademarks”); 

(b) all Trademark licenses for the grant by or to the Grantor of any right to use any Trademark, including each Trademark
license referred to in Item B of Schedule I hereto; 
 (c) all of the goodwill of the business connected with
the use of, and symbolized by the items described in, clause (a), and to the extent applicable, clause (b); 

(d) the right to sue third parties for past, present and future infringements of any Trademark Collateral described in
clause (a) and, to the extent applicable, clause (b); and 
 (e) all Proceeds of, and rights associated
with, the foregoing, including any claim by the Grantor against third parties for past, present or future infringement or dilution of any Trademark, Trademark registration or Trademark license, or for any injury to the goodwill associated with the
use of any such Trademark or for breach or enforcement of any Trademark license and all rights corresponding thereto throughout the world. 

SECTION 3. Security Agreement. This Agreement has been executed and delivered by the Grantor for the purpose of registering the
security interest of the Lender in the Trademark Collateral with the United States Patent and Trademark Office. The security interest granted hereby has been granted in furtherance of, and not in limitation of, the security interest granted to the
Lender for its benefit under the Security Agreement. The Security Agreement (and all rights and remedies of the Lender thereunder) shall remain in full force and effect in accordance with its terms. 

SECTION 4. Release of Liens. Upon (i) the Disposition of Trademark Collateral in accordance with the Credit Agreement or
(ii) the occurrence of the Termination Date, the security interests granted herein shall automatically terminate with respect to (A) such Trademark Collateral (in the case of clause (i)) or (B) all Trademark Collateral (in the
case of clause (ii)). Upon any such Disposition or termination, the Lender will, at the Grantor’s sole expense, deliver to the Grantor, without any representations, warranties or recourse of any kind whatsoever, all Trademark Collateral
held by the Lender hereunder, and execute and deliver to the Grantor such documents as the Grantor shall reasonably request to evidence such termination. 

  
 2 









 Exhibit 10.8 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 SECTION 5. Acknowledgment. The Grantor does hereby further acknowledge and affirm that
the rights and remedies of the Lender with respect to the security interest in the Trademark Collateral granted hereby are more fully set forth in the Security Agreement, the terms and provisions of which (including the remedies provided for
therein) are incorporated by reference herein as if fully set forth herein. 
 SECTION 6. Loan Document. This Agreement is a Loan
Document executed pursuant to the Credit Agreement and shall (unless otherwise expressly indicated herein) be construed, administered and applied in accordance with the terms and provisions thereof, including Article X thereof. 

SECTION 7. Effective. This Agreement shall become effective when a counterpart hereof executed by the Grantor, shall have been received
by the Lender. Delivery of an executed counterpart of a signature page to this Agreement by email (e.g. “pdf” or “tiff”) or telecopy shall be effective as delivery of a manually executed counterpart of this Agreement. 

[Signature Page Follows] 

  
 3 









 Exhibit 10.8 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 IN WITNESS WHEREOF, the Grantor hereto has caused this Agreement to be duly executed and
delivered by Authorized Officer as of the date first above written. 
  

			
	[NAME OF GRANTOR]
		
	By:	 	  

		 	Name:
		 	Title:



  
 4 









 Exhibit 10.8 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 SCHEDULE I 

to Trademark Security Agreement 
 Item A.
Trademarks 
 Registered Trademarks 
  

							
	 Country
	  	 Trademark
	  	 Registration No.
	  	 Registration Date



Pending Trademark Applications 
  

							
	 Country
	  	 Trademark
	  	 Serial No.
	  	 Filing Date



Trademark Applications in Preparation 
  

									
	 	  	 	  	 	  	Expected	  	Products/
	 Country
	  	 Trademark
	  	 Docket No.
	  	 Filing Date
	  	 Services



Item B. Trademark Licenses 
  

											
	Country or	  	 	  	 	  	 	  	Effective	  	Expiration
	 Territory
	  	 Trademark
	  	 Licensor
	  	 Licensee
	  	 Date
	  	 Date



  
 1 









 Exhibit 10.8 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 EXHIBIT C 

to Security Agreement 
 COPYRIGHT
SECURITY AGREEMENT 
 This COPYRIGHT SECURITY AGREEMENT, dated as of
                 , 20     (this “Agreement”), is made by [NAME OF GRANTOR], a
                          (the “Grantor”), in favor of ROS ACQUISITION OFFSHORE LP, a Cayman Islands exempted
limited partnership, for itself and as agent for the other parties to which the Grantor may owe any Obligations (together with its Affiliates, successors, transferees and assignees, the “Lender”). 

W I T N E S S E T H : 

WHEREAS, pursuant to a Credit Agreement, dated as of [            ], 2014 (as
amended, supplemented, or otherwise modified from time to time, the “Credit Agreement”), among by and between Unilife Medical Solutions, Inc., a Delaware corporation (the “Borrower”) and the Lender, the Lender has
extended a Commitment to make the Loans to the Borrower; 
 WHEREAS, in connection with the Credit Agreement, the Grantor and its Affiliates
have executed and delivered a Pledge and Security Agreement in favor of the Lender, dated as of [            ], 2014 (as amended, supplemented, or otherwise modified from time to time, the
“Security Agreement”); 
 WHEREAS, pursuant to the Credit Agreement and pursuant to clause (e) of Section 4.5 of
the Security Agreement, the Grantor is required to execute and deliver this Agreement and to grant to the Lender a continuing security interest in all of the Copyright Collateral (as defined below) to secure all of the Obligations; and 

WHEREAS, the Grantor has duly authorized the execution, delivery and performance of this Agreement; 

NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Grantor agrees, for the
benefit of the Lender, as follows: 
 SECTION 1. Definitions. Unless otherwise defined herein or the context otherwise requires, terms
used in this Agreement, including its preamble and recitals, have the meanings provided (or incorporated by reference) in the Security Agreement. 

SECTION 2. Grant of Security Interest. The Grantor hereby grants to the Lender, for its benefit, a continuing security interest in all
of the Grantor’s right, title and interest in and to the following (the “Copyright Collateral”), whether now or hereafter existing or acquired by the Grantor: all copyrights of the Grantor, whether statutory or common law,
whether registered or 

  
 1 









 Exhibit 10.8 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 
unregistered and whether published or unpublished, now or hereafter in force throughout the world including all of the Grantor’s right, title and interest in and to all copyrights registered
in the United States Copyright Office or anywhere else in the world including the copyrights referred to in Item A of Schedule I hereto, and registrations and recordings thereof and all applications for registration thereof, whether
pending or in preparation, all copyright licenses, including each copyright license referred to in Item B of Schedule I hereto, the right to sue for past, present and future infringements of any of the foregoing, all rights
corresponding thereto, all extensions and renewals of any thereof and all Proceeds of the foregoing, including licenses, royalties, income, payments, claims, damages and Proceeds of suit. 

SECTION 3. Security Agreement. This Agreement has been executed and delivered by the Grantor for the purpose of registering the
security interest of the Lender in the Copyright Collateral with the United States Copyright Office. The security interest granted hereby has been granted in furtherance of, and not in limitation of, the security interest granted to the Lender for
its benefit under the Security Agreement. The Security Agreement (and all rights and remedies of the Lender thereunder) shall remain in full force and effect in accordance with its terms. 

SECTION 4. Release of Liens. Upon (i) the Disposition of Copyright Collateral in accordance with the Credit Agreement or
(ii) the occurrence of the Termination Date, the security interests granted herein shall automatically terminate with respect to (A) such Copyright Collateral (in the case of clause (i)) or (B) all Copyright Collateral (in the
case of clause (ii)). Upon any such Disposition or termination, the Lender will, at the Grantor’s sole expense, deliver to the Grantor, without any representations, warranties or recourse of any kind whatsoever, all Copyright Collateral
held by the Lender hereunder, and execute and deliver to the Grantor such documents as the Grantor shall reasonably request to evidence such termination. 

SECTION 5. Acknowledgment. The Grantor does hereby further acknowledge and affirm that the rights and remedies of the Lender with
respect to the security interest in the Copyright Collateral granted hereby are more fully set forth in the Security Agreement, the terms and provisions of which (including the remedies provided for therein) are incorporated by reference herein as
if fully set forth herein. 
 SECTION 6. Loan Document. This Agreement is a Loan Document executed pursuant to the Credit Agreement
and shall (unless otherwise expressly indicated herein) be construed, administered and applied in accordance with the terms and provisions thereof, including Article X thereof. 

SECTION 7. Effective. This Agreement shall become effective when a counterpart hereof executed by the Grantor, shall have been received
by the Lender. Delivery of an executed counterpart of a signature page to this Agreement by email (e.g. “pdf” or “tiff”) or telecopy shall be effective as delivery or a manually executed counterpart of this Agreement. 

[Signature Page Follows] 

  
 2 









 Exhibit 10.8 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 IN WITNESS WHEREOF, the Grantor hereto has caused this Agreement to be duly executed and
delivered by its Authorized Officer as of the date first above written. 
  

			
	[NAME OF GRANTOR]
		
	By:	 	 
		 	Name:
		 	Title:



  
 3 









 Exhibit 10.8 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 SCHEDULE I 

to Copyright Security Agreement 
 Item A.
Copyrights/Mask Works 
 Registered Copyrights/Mask Works 

 

									
	 Country
	  	 Registration No.
	  	 Registration Date
	  	 Author(s)
	  	 Title



Copyright/Mask Work Pending Registration Applications 
  

									
	 Country
	  	 Serial No.
	  	 Filing Date
	  	 Author(s)
	  	 Title



Copyright/Mask Work Registration Applications in Preparation 
  

									
	 	  	 	  	Expected	  	 	  	 
	 Country
	  	 Docket No.
	  	 Filing Date
	  	 Author(s)
	  	 Title



Item B. Copyright/Mask Work Licenses 
  

									
	Country or	  	 	  	 	  	Effective	  	Expiration
	 Territory
	  	 Licensor
	  	 Licensee
	  	 Date
	  	 Date



  
 1 









 Exhibit 10.8 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 ANNEX I 

to Security Agreement 
 SUPPLEMENT
TO 
 PLEDGE AND SECURITY AGREEMENT 

This SUPPLEMENT, dated as of                  ,
20     (this “Supplement”), is to the Pledge and Security Agreement, dated as of [            ], 2014 (as amended, supplemented, amended and restated or
otherwise modified from time to time, the “Security Agreement”), among the Grantors (such term, and other terms used in this Supplement, to have the meanings set forth in Article I of the Security Agreement) from time to time party
thereto, in favor of ROS ACQUISITION OFFSHORE LP, a Cayman Islands exempted limited partnership, for itself and as agent for the other parties to which the undersigned may owe any Obligations (together with its Affiliates, successors, transferees
and assignees, the “Lender”). 
 W I T N E S S E T H :

 WHEREAS, pursuant to a Credit Agreement, dated as of [            ], 2014 (as
amended, supplemented, or otherwise modified from time to time, the “Credit Agreement”), by and between Unilife Medical Solutions, Inc., a Delaware corporation (the “Borrower”) and the Lender, the Lender has
extended a Commitment to make the Loans to the Borrower; 
 WHEREAS, pursuant to the provisions of Section 7.6 of the Security
Agreement, each of the undersigned is becoming a Grantor under the Security Agreement; and 
 WHEREAS, each of the undersigned desires to
become a “Grantor” under the Security Agreement in order to induce the Lender to continue to extend Loans under the Credit Agreement; 

NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, each of the undersigned
agrees, for the benefit of the Lender, as follows. 
 SECTION 1. Party to Security Agreement, Etc. In accordance with the terms of
the Security Agreement, by its signature below, each of the undersigned hereby irrevocably agrees to become a Grantor under the Security Agreement with the same force and effect as if it were an original signatory thereto and each of the undersigned
hereby (a) agrees to be bound by and comply with all of the terms and provisions of the Security Agreement applicable to it as a Grantor and (b) represents and warrants that the representations and warranties made by it as a Grantor
thereunder are true and correct as of the date hereof, unless stated to relate solely to an earlier date, in which case such representations and warranties shall be true and correct as of such earlier date. In furtherance of the foregoing, each
reference to a “Grantor” and/or “Grantors” in the Security Agreement shall be deemed to include each of the undersigned. 

  
 1 









 Exhibit 10.8 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 SECTION 2. Schedules. Each of the undersigned Grantors hereby authorizes the Lender to
add the information set forth on the Schedules to this Supplement to the correlative Schedules attached to the Security Agreement. 

SECTION 3. Representations. Each of the undersigned Grantors hereby represents and warrants that this Supplement has been duly
authorized, executed and delivered by it and that this Supplement and the Security Agreement constitute its legal, valid and binding obligation, enforceable against it in accordance with its terms. 

SECTION 4. Full Force of Security Agreement. Except as expressly supplemented hereby, the Security Agreement shall remain in full force
and effect in accordance with its terms. 
 SECTION 5. Severability. Wherever possible each provision of this Supplement shall be
interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Supplement shall be prohibited by or invalid under such law, such provision shall be ineffective to the extent of such prohibition or
invalidity, without invalidating the remainder of such provision or the remaining provisions of this Supplement or the Security Agreement. 

SECTION 6. Governing Law, Entire Agreement, Etc. THIS SUPPLEMENT AND ANY CLAIMS, CONTROVERSY, DISPUTE OR CAUSE OF ACTION (WHETHER IN
CONTRACT OR TORT OR OTHERWISE) BASED UPON, ARISING OUT OF OR RELATING TO THIS SECURITY AGREEMENT OR ANY DOCUMENT CONTEMPLATED HEREBY SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE INTERNAL LAWS OF THE STATE OF NEW YORK (INCLUDING FOR
SUCH PURPOSE SECTIONS 5-1401 AND 5-1402 OF THE GENERAL OBLIGATIONS LAW OF THE STATE OF NEW YORK). This Supplement, along with the other Loan Documents, constitutes the entire understanding among the parties
hereto with respect to the subject matter thereof and supersedes any prior agreements, written or oral, with respect thereto. 
 SECTION 7.
Effective. This Supplement shall become effective when a counterpart hereof executed by the Grantor shall have been received by the Lender. Delivery of an executed counterpart of a signature page to this Supplement by email (e.g.
“pdf” or “tiff”) or telecopy shall be effective as delivery of a manually executed counterpart of this Supplement. 

[Signature Page Follows] 

  
 2 









 Exhibit 10.8 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 IN WITNESS WHEREOF, each of the parties hereto has caused this Supplement to be duly executed
and delivered by its Authorized Officer as of the date first above written. 
  

			
	[NAME OF ADDITIONAL SUBSIDIARY]
		
	By:	 	 
		 	Name:
		 	Title:
	
	[NAME OF ADDITIONAL SUBSIDIARY]
		
	By:	 	 
		 	Name:
		 	Title:



  
 3 









 Exhibit 10.8 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 [COPY SCHEDULES FROM SECURITY AGREEMENT] 

  
 4 









 Exhibit 10.8 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 [***] 

[***] 
 [see attached]